Virinchi Ltd

Virinchi Other Announcement

Virinchi Ltd has dispatched letters to shareholders with the weblink for the Annual Report for FY 2025-26, in compliance with SEBI Listing Regulations.

Virinchi Annual General Meeting

Virinchi Limited has issued a notice for its 37th Annual General Meeting, scheduled for September 30, 2026, to be conducted via video conferencing.

Virinchi Annual Report

Virinchi Ltd submitted its Annual Report and notice for the 37th AGM scheduled on September 30, 2026, to the stock exchanges.

Virinchi Board Meeting Outcome

Virinchi Ltd announced the outcome of its board meeting, including the date for its 37th Annual General Meeting and the reappointment of a director.

Virinchi Q1 FY27 Results: Net Loss of ₹2.1 Cr

Virinchi Ltd reported revenue from operations of ₹70.1 Cr (-12.0% YoY) and a net loss of ₹2.1 Cr for Q1 FY27.

Key figure

Net loss ₹2.1 Cr

Virinchi Annual General Meeting

Virinchi Ltd announced voting results for a postal ballot approving the acquisition of a healthcare business division from its subsidiary, Virinchi Health Care Private Limited.

Virinchi Merger & Restructuring

Virinchi Ltd shareholders approved the slump sale acquisition of the Bristlecone Hospitals business division from its material subsidiary, Virinchi Health Care Private Limited, via postal ballot.

Virinchi Board Meeting Date

Virinchi Ltd has scheduled a board meeting for August 13, 2026, to consider and approve the company's standalone and consolidated financial results for the quarter.

Virinchi Annual General Meeting

Virinchi Limited announced the approval of postal ballot resolutions. Shareholders approved loans under Section 185 and material related party transactions with Virinchi Health Care and Vivo Bio Tech.

Virinchi Results Correction

Virinchi Limited filed revised XBRL financials for FY26 to correct EPS and PAT mismatches. The revisions follow an NSE clarification request dated June 25, 2026.

Virinchi Annual General Meeting

Virinchi Ltd seeks shareholder approval via postal ballot to acquire its healthcare division for Rs.100 Crore. Voting runs from July 12 to August 10, 2026.

Value

₹100.0 Cr

Virinchi Merger & Restructuring Worth ₹82.99 Cr

Virinchi Limited approved a slump sale acquisition of its subsidiary's healthcare division. The unit reported ₹82.99 Crore turnover, with completion expected by August 2026.

Value

₹82.99 Cr

Execution

Expected completion by August 31, 2026

Virinchi Merger & Restructuring Worth ₹100 Cr

Virinchi Limited approved the acquisition of Bristlecone Hospitals' healthcare division for Rs.100 Crore. The transaction will be executed via a slump sale from its material subsidiary.

Value

₹100.0 Cr

Execution

Transaction effective from April 1, 2026